Showing results (1711-1720 of 3,072) with videos related to

Sort By:
Pageof 308
Chemotherapy|January 1, 1989
Studies on antifungal agents. 19. Effect of the C-5-aromatic substitution on the in vitro activity of novel 3,5-substituted isoxazolidinesG B Mullen, J T Mitchell, S D Allen, et al.
Chemotherapy|November 13, 2015
Multidrug-Resistant Escherichia coli Strains Isolated from Patients Are Associated with Class 1 and 2 IntegronsHamid Lavakhamseh, Parviz Mohajeri, Samaneh Rouhi, et al.
Chemotherapy|March 2, 2016
Gemcitabine-Induced Subacute Cutaneous Lupus Erythematosus: A Case ReportMasha Ben Zvi, Hananya Vaknine, Joseph Menczer, et al.
Chemotherapy|April 9, 2016
Clinical Impact of Bevacizumab in Patients with Relapsed Glioblastoma: Focus on a Real-Life Monocentric SurVey (SV1 Study)Romain Rivoirard, Cyrus Chargari, Jean-Baptiste Guy, et al.
Chemotherapy|April 9, 2016
Antibiotic Resistance Patterns and a Survey of Metallo-β-Lactamase Genes Including bla-IMP and bla-VIM Types in Acinetobacter baumannii Isolated from Hospital Patients in TehranSamira Aghamiri, Nour Amirmozafari, Jalil Fallah Mehrabadi, et al.
Chemotherapy|October 27, 2015
Addition of Cladribine to Idarubicin and Cytarabine during Induction Increases the Overall Efficacy Rate in Adult Patients with Acute Myeloid Leukemia: A Matched-Pair Retrospective ComparisonYaoyao Shen, Jia Chen, Yuejun Liu, et al.
Chemotherapy|October 27, 2015
Bacterial Quorum Sensing Inhibition Activity of the Traditional Chinese Herbs, Ficus carica L. and Perilla frutescensShiwei Sun, Hui Li, Wanlong Zhou, et al.
Chemotherapy|October 31, 2015
Comparison of the Efficacy between Pemetrexed plus Platinum and Non-Pemetrexed plus Platinum as First-Line Treatment in Patients with Wild-Type Epidermal Growth Factor Receptor Nonsquamous Non-Small Cell Lung Cancer: A Retrospective AnalysisEun Joo Kang, Kyung Hoon Min, Gyu Young Hur, et al.
Chemotherapy|November 4, 2015
Low-Dose Docetaxel Combined with Dexamethasone Is Feasible for Patients with Castration-Resistant Prostate CancerNoriyoshi Miura, Nozomu Tanji, Yutaka Yanagihara, et al.
Chemotherapy|June 12, 2016
GEMOX: An Active Regimen for the Treatment of Luminal and Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast CancerAnna Rizzi, Francesca Aroldi, Paola Bertocchi, et al.
Pageof 308